Clinical Trials Sponsored by Partners HealthCare

Total 4628 results

Massachusetts General Hospital
Partners HealthCare

Completed

A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians

Depression | Low Back Pain
Brigham and Women's Hospital
Partners HealthCare

Active, not recruiting

Addressing Disparities in Lupus Care Through an Integrated Care Management Program (Rheum-iCMP)

Systemic Lupus Erythematosus

United States
Brigham and Women's Hospital
Partners HealthCare

Completed

Palliative Care Population Management Project for Integrated Care Management Program for High-Risk Patients (iCMP)

Failure to Thrive

United States
Massachusetts General Hospital
Partners HealthCare, Inc.

Completed

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc. (PiHQ)

Smoking Cessation | Tobacco Use Disorder

United States
AltheaDx
Carolina Partners in Mental Healthcare

Completed

Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

Depression | Anxiety

United States
Cogito Health Inc
Massachusetts General Hospital; Partners HealthCare

Completed

Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Depression | Bipolar Disorder

United States
Manistee Partners

Unknown

Topical Bimatoprost in the Treatment of Migraine

Migraine Disorders | Headache Disorders

United States
HealthCore-NERI
Bayer; Besins Healthcare

Completed

Registry of Hypogonadism in Men (RHyMe)

Male Hypogonadism | Testosterone Deficiency | Androgen Deficiency

Italy, United Kingdom, Spain, Netherlands, Germany, Sweden
Open Innovation Partners, Inc.
Open Innovation Partners

Suspended

TR1801-ADC in Patients With Tumors That Express c-Met

Unspecified Adult Solid Tumor, Protocol Specific

United States
Molecular Partners AG

Recruiting

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Leukemia | Acute | Relapsed | Myeloid

Netherlands, France, Lithuania, Switzerland
Tetra Discovery Partners

Recruiting

A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Fragile X Syndrome

United States
Molecular Partners AG

Terminated

MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC

EGFR-mutated NSCLC (Disorder)

United States
Molecular Partners AG

Completed

Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

France
Molecular Partners AG

Terminated

Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19)

COVID-19

United Kingdom
Molecular Partners AG

Completed

First-in-human Study to Investigate Safety, Blood Levels and Activity of MP0274 in Cancer Patients With HER2-positive Solid Tumors

Neoplasms

Germany, Switzerland, United Kingdom
Tetra Discovery Partners

Withdrawn

A Phase 1, Open-Label, PET Study of T2310 & BPN14770

To Determine Brain Target Occupancy of BPN14770

United States
Tetra Discovery Partners

Completed

A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome

Fragile X Syndrome | Fra(X) Syndrome | FXS

United States
Tetra Discovery Partners

Completed

Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

Alzheimer Disease

United States
A.A. Partners, LLC

Unknown

3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (3-D-TEBE)

Bone Defects

Ukraine
A.A. Partners, LLC

Unknown

Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs) (ADSCs-BWs)

Second- or Third-degree Burns

Ukraine
Molecular Partners AG

Completed

Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients

Covid19

Netherlands
Molecular Partners AG

Completed

A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma in Relapse

Poland, Italy, Germany, Denmark, Czechia, Austria
Tetra Discovery Partners

Unknown

Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects

Alzheimer's Disease

United States
Partners in Health

Unknown

Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3) (SHARED3)

Hepatitis C, Chronic

Rwanda
Molecular Partners AG

Completed

First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients

Neoplasms

Switzerland, Spain, United Kingdom
Tetra Discovery Partners

Completed

BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects

Alzheimer's Disease

United States
Tetra Discovery Partners

Recruiting

A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

Fragile X Syndrome

United States
Cardio Surgical Partners

Recruiting

Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol

SCS

United States
Molecular Partners AG

Terminated

First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors

Advanced Malignant Solid Tumor

Netherlands, France
Tetra Discovery Partners

Enrolling by invitation

An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome

Fragile X Syndrome

United States
Partners in Health

Completed

Simplifying Hepatitis C Antiviral Therapy in Rwanda for Elsewhere in the Developing World (SHARED)

Chronic Hepatitis C

Rwanda
Tetra Discovery Partners

Completed

A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects

Alzheimer's Disease

United States
Cereal Partners Worldwide

Completed

Effects of Whole Grain on Weight Maintenance

Body Weight | Abdominal Fat

France
Boston University
National Center for Complementary and Integrative Health (NCCIH); Partners...

Completed

The Treatment of Depression With Yoga and Walking

Depression | PTSD | Anxiety | Major Depressive Disorder

United States
Harvard University
Genzyme, a Sanofi Company; Blue Cross Blue Shield; Partners HealthCare

Withdrawn

Financial Incentives for Increasing Exercise

Obesity | Sedentary Lifestyle

United States
Brigham and Women's Hospital
Johns Hopkins University; Case Western Reserve University; Partners HealthCare; VA Boston Healthcare System

Completed

Heart Biomarker Evaluation in Apnea Treatment (HeartBEAT)

Coronary Artery Disease | Cardiovascular Disease | Obstructive Sleep Apnea

United States
Nuvectra
Bright Research Partners

Terminated

Algovita Spinal Cord Stimulation System Hi-Fi Study

Chronic Pain

United States
ETOP IBCSG Partners Foundation

Completed

TRial on the Endocrine Activity of Neoadjuvant Degarelix (TREND)

Breast Cancer Invasive Nos

Italy
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema

Diabetic Macular Edema

United States
Allergan
Molecular Partners AG

Terminated

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Wet Age-Related Macular Degeneration

Switzerland, France, Czech Republic
Reproductive Partners Medical Group

Terminated

Effect of Omega 3 Fats on Sperm Quality and Sexual Function

Infertility

United States
ETOP IBCSG Partners Foundation

Completed

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer (12-93)

Breast Cancer

Switzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
ETOP IBCSG Partners Foundation

Completed

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer (10-93)

Breast Cancer

Switzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
ETOP IBCSG Partners Foundation

Withdrawn

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Breast Cancer | Osteoporosis

Switzerland
Infraredx
Bright Research Partners

Completed

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)

Coronary Stenosis | Coronary Artery Stenosis | In-stent Restenosis

United States
Duke University
Reinvestment Partners

Completed

Durham Healthy Breathing in Healthy Homes Project (DHBHH)

Poor Asthma Control

United States
ETOP IBCSG Partners Foundation

Completed

Afatinib in NSCLC With HER2 Mutation (NICHE)

NSCLC

Switzerland, Germany, Spain, Netherlands
ETOP IBCSG Partners Foundation

Completed

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02 (SOFT-EST)

Breast Cancer

Spain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
ETOP IBCSG Partners Foundation

Terminated

IBCSG Trial 22-00 Serum Substudy

Breast Cancer

Peru, Italy, Nigeria
ETOP IBCSG Partners Foundation

Completed

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (23-01)

Breast Cancer

France, Switzerland, Australia, Peru, Italy, New Zealand, Slovenia, Belgium, Brazil, Denmark

Clinical Trials Sponsored by Partners HealthCare

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations